InvestorsHub Logo

DewDiligence

08/14/20 6:28 PM

#234228 RE: marthambles #234165

RVNC—The 0.9% ptosis rate observed in SAKURA-3 is even better than the 2.2% rate for (non-placebo) patients in SAKURA-1/2 (https://www.jaad.org/article/S0190-9622(19)32459-4/fulltext ).